Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Confirmatory study of HFT-290 fentanyl patch in patients with chronic pain
jRCT2080221563Phase 3
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fentanyl in chronic pain, sponsored by Hisamitsu Pharmaceutical Co., Inc.
02
Drugs
fentanyl
03
Conditions
chronic pain
Beyond the preview
Go deeper on jRCT2080221563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221563.